论文部分内容阅读
本文对65例糖尿病人进行了肾糖阈测定,结果发现44.6％的糖尿病患者肾糖阈异常,其中15例肾糖阈降低,占23.1％,血糖在2.8—5.9mmol/L时仍有糖尿排出(+—(?)),14例肾糖阈升高,占21.5％,血糖在11.2—14.5mmol/L时尿糖仍阴性。糖尿病人肾糖阈改变与患者年龄,病程、上糖值无关,P>0.05。 糖尿病人有肾糖阈异常,尿糖测定就不能正确反映其血糖水平,肾糖阈降低的患者,临床上会呈现控制不良假象。肾糖阈升高的患者,又会造成用药量偏小,使血糖不能及时得到满意控制。因此用尿糖作为糖尿病患者的病情监测并指导合理用药时,有必要对糖尿病人进行肾糖阀定。
In this paper, 65 cases of diabetic patients were measured renal glucose threshold and found that 44.6% of diabetic patients with abnormal renal glucose threshold, including 15 cases of renal glucose threshold decreased, accounting for 23.1%, 2.8-5.9 mmol / L of blood glucose still have diabetes when excreted (+ - (?)), 14 cases of elevated renal glucose threshold, accounting for 21.5%, blood glucose at 11.2-14.5mmol / L, urine is still negative. Diabetic patients with changes in renal glucose threshold and age, duration, no value of sugar, P> 0.05. Diabetic patients with abnormal renal glucose threshold, urine glucose measurement can not correctly reflect the level of their blood sugar, renal glucose threshold decreased in patients with clinical control will appear illusion. Patients with elevated renal glucose threshold, will result in smaller doses, so that blood glucose can not be satisfied with the timely control. Therefore, the use of urine glucose as a diabetic patient’s condition monitoring and guidance of rational drug use, it is necessary for diabetic patients with renal glucose valve set.